Private Equity in Healthcare: FTC v. U.S. Anesthesia Partners and Welsh Carson

The Federal Trade Commission (FTC) and Department of Justice focus on investigating the impact of consolidation in healthcare. Recently, they have expressed a renewed interest in for-profit medicine. The FTC’s challenge of U.S. Anesthesia Partners and Welsh, Carson, Anderson & Stowe, in which the agency accused the parties of engaging in a three-pronged strategy to amass monopoly power and extract monopoly profits, raises the issue of liability of private equity firms’ investment in roll-ups and acquisitions.

Consultant Ruhi Sohal and her co-author explore the FTC’s allegations as well as the literature on trends and the impact of private equity in healthcare. Read the article here (subscription/membership required).